泛素特异性蛋白酶42调节人脂肪干细胞成骨向分化

doi:10.19723/j.issn.1671-167X.2024.01.003

摘要/Abstract

摘要：

目的: 探索泛素特异性蛋白酶42(ubiquitin-specific protease 42，USP42)在人脂肪干细胞(human adipose-derived stem cells，hASCs)体内外成骨向分化中的作用。方法: 用慢病毒转染hASCs，构建敲低和过表达USP42的稳定转染细胞系，通过碱性磷酸酶(alkaline phosphatase，ALP)染色及活性定量、茜素红S矿化结节染色及定量，检测实验组(敲低组和过表达组)及对照组在成骨诱导下hASCs成骨向分化能力的差异，通过定量逆转录聚合酶链反应(quantitative reverse transcription polymerase chain reaction，qRT-PCR)检测实验组及对照组成骨相关基因的表达水平，通过蛋白免疫印迹实验检测实验组及对照组成骨相关蛋白的表达水平，通过裸鼠异位成骨实验评价USP42在hASCs体内成骨向分化中的作用。结果: 敲低组USP42的mRNA和蛋白表达显著低于对照组，过表达组显著高于对照组。成骨诱导7 d后，敲低组的ALP活性显著高于对照组，过表达组显著低于对照组；成骨诱导14 d后，敲低组茜素红S染色显著深于对照组，过表达组显著浅于对照组。qRT-PCR结果显示，成骨诱导14 d时，敲低组ALP、成骨细胞特异性转录因子(osterix，OSX)和Ⅰ型胶原(collagen type Ⅰ，COLⅠ)的mRNA表达水平显著高于对照组，过表达组显著低于对照组。蛋白免疫印迹实验结果显示，成骨诱导14 d时敲低组runt相关转录因子2(runt-related transcription factor 2，RUNX2)、OSX和COLⅠ蛋白表达水平显著高于对照组，过表达组显著低于对照组。裸鼠皮下移植物苏木精-伊红染色结果显示，敲低组类骨组织百分比较对照组显著增高。结论: 敲低USP42显著促进hASCs的体内外成骨向分化，过表达USP42显著抑制hASCs的体内成骨向分化，USP42可作为骨组织工程学潜在治疗靶点。

关键词: 泛素特异性蛋白酶类, 人脂肪干细胞, 细胞分化, 骨和骨组织, 再生医学

Abstract:

Objective: To explore the effect of ubiquitin-specific protease 42 (USP42) on osteogenic differentiation of human adipose-derived stem cells (hASCs) in vivo and in vitro. Methods: A combination of experiments was carried out with genetic depletion of USP42 using a lentiviral strategy. Alkaline phosphatase (ALP) staining and quantification, alizarin red S (ARS) staining and quantification were used to determine the osteogenic differentiation ability of hASCs under osteogenic induction between the experimental group (knockdown group and overexpression group) and the control group. Quantitative reverse transcription PCR (qRT-PCR) was used to detect the expression levels of osteogenesis related genes in the experimental group and control group, and Western blotting was used to detect the expression levels of osteogenesis related proteins in the experimental group and control group. Nude mice ectopic implantation experiment was used to evaluate the effect of USP42 on the osteogenic differentiation of hASCs in vivo. Results: The mRNA and protein expressions of USP42 in knockdown group were significantly lower than those in control group, and those in overexpression group were significantly higher than those in control group. After 7 days of osteogenic induction, the ALP activity in the knockdown group was significantly higher than that in the control group, and ALP activity in overexpression group was significantly lower than that in control group. After 14 days of osteogenic induction, ARS staining was significantly deeper in the knockdown group than in the control group, and significantly lighter in overexpression group than in the control group. The results of qRT-PCR showed that the mRNA expression levels of ALP, osterix (OSX) and collagen type Ⅰ (COLⅠ) in the knockdown group were significantly higher than those in the control group after 14 days of osteogenic induction, and those in overexpression group were significantly lower than those in control group. The results of Western blotting showed that the expression levels of runt-related transcription factor 2 (RUNX2), OSX and COLⅠ in the knockout group were significantly higher than those in the control group at 14 days after osteogenic induction, while the expression levels of RUNX2, OSX and COLⅠ in the overexpression group were significantly lower than those in the control group. Hematoxylin-eosin staining of subcutaneous grafts in nude mice showed that the percentage of osteoid area in the knockdown group was significantly higher than that in the control group. Conclusion: Knockdown of USP42 can significantly promote the osteogenic differentiation of hASCs in vitro and in vivo, and overexpression of USP42 significantly inhibits in vivo osteogenic differentiation of hASCs, and USP42 can provide a potential therapeutic target for bone tissue engineering.

Key words: Ubiquitin-specific proteases, Human adipose-derived stem cells, Cell differentiation, Bone and bones, Regenerative medicine

中图分类号:

R318

潘媛,顾航,肖涵,赵笠君,汤祎熳,葛雯姝. 泛素特异性蛋白酶42调节人脂肪干细胞成骨向分化[J]. 北京大学学报（医学版）, 2024, 56(1): 9-16.

Yuan PAN,Hang GU,Han XIAO,Lijun ZHAO,Yiman TANG,Wenshu GE. Ubiquitin-specific protease 42 regulates osteogenic differentiation of human adipose-derived stem cells[J]. Journal of Peking University (Health Sciences), 2024, 56(1): 9-16.

图/表 14

表1

图1

图2

图3

图4

图5

图6

图7

图8

图9

图10

图11

图12

图13

参考文献 25

1	Lin H , Sohn J , Shen H , et al. Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing[J]. Biomaterials, 2019, 203, 96- 110. doi: 10.1016/j.biomaterials.2018.06.026
2	Bunpetch V , Zhang Z Y , Zhang X , et al. Strategies for MSC expansion and MSC-based microtissue for bone regeneration[J]. Biomaterials, 2019, 196, 67- 79. doi: 10.1016/j.biomaterials.2017.11.023
3	刘云松, 周永胜, 葛雯姝, 等. 原代人脂肪基质细胞体内成骨能力的检测[J]. 北京大学学报(医学版), 2012, 44 (1): 55- 58. doi: 10.3969/j.issn.1671-167X.2012.01.012
4	周永胜, 刘云松, 葛雯姝, 等. 人脂肪基质细胞在骨组织工程学中的应用[J]. 北京大学学报(医学版), 2012, 44 (1): 160- 162.
5	Snyder NA , Silva GM . Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response[J]. J Biol Chem, 2021, 297 (3): 101077. doi: 10.1016/j.jbc.2021.101077
6	Ge F , Li Y , Yuan T , et al. Deubiquitinating enzymes: Promising targets for drug resistance[J]. Drug Discov Today, 2022, 27 (9): 2603- 2613. doi: 10.1016/j.drudis.2022.06.009
7	Wang X . Stem cells in tissues, organoids, and cancers[J]. Cell Mol Life Sci, 2019, 76 (20): 4043- 4070. doi: 10.1007/s00018-019-03199-x
8	Guo YC , Zhang SW , Yuan Q . Deubiquitinating enzymes and bone remodeling[J]. Stem Cells Int, 2018, 2018, 3712083.
9	Suresh B , Lee J , Kim H , et al. Regulation of pluripotency and differentiation by deubiquitinating enzymes[J]. Cell Death Differ, 2016, 23 (8): 1257- 1264. doi: 10.1038/cdd.2016.53
10	Tang YM , Lv LW , Li WY , et al. Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells[J]. Stem Cell Res Ther, 2017, 8 (1): 186. doi: 10.1186/s13287-017-0637-8
11	Hock AK , Vigneron AM , Vousden KH . Ubiquitin-specific peptidase 42 (USP42) functions to deubiquitylate histones and regulate transcriptional activity[J]. J Biol Chem, 2014, 289 (50): 34862- 34870. doi: 10.1074/jbc.M114.589267
12	Hock AK , Vigneron AM , Carter S , et al. Regulation of p53 stability and function by the deubiquitinating enzyme USP42[J]. EMBO J, 2011, 30 (24): 4921- 4930. doi: 10.1038/emboj.2011.419
13	Giebel N , De Jaime-Soguero A , Garcia Del Arco A , et al. USP42 protects ZNRF3/RNF43 from R-spondin-dependent clearance and inhibits Wnt signalling[J]. EMBO Rep, 2021, 22 (5): e51415. doi: 10.15252/embr.202051415
14	Orkin SH , Hochedlinger K . Chromatin connections to pluripotency and cellular reprogramming[J]. Cell, 2011, 145 (6): 835- 850. doi: 10.1016/j.cell.2011.05.019
15	Atlasi Y , Stunnenberg HG . The interplay of epigenetic marks during stem cell differentiation and development[J]. Nat Rev Genet, 2017, 18 (11): 643- 658. doi: 10.1038/nrg.2017.57
16	Reyes-Thrcu FE , Wilkinson KD . Polyubiquitin binding and dis-assembly by deubiquitinating enzymes[J]. Chem Rev, 2009, 109 (4): 1495- 1508. doi: 10.1021/cr800470j
17	Frezza M , Schmitt S , Dou QP . Targeting the ubiquitin-proteasome pathway: An emerging concept in cancer therapy[J]. Curr Top Med Chem, 2011, 11 (23): 2888- 2905. doi: 10.2174/156802611798281311
18	Das T , Shin SC , Song EJ , et al. Regulation of deubiquitinating enzymes by post-translational modifications[J]. Int J Mol Sci, 2020, 21 (11): 4028. doi: 10.3390/ijms21114028
19	Sun X , Xie Z , Ma Y , et al. TGF-beta inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling[J]. J Cell Physiol, 2018, 233 (1): 596- 606. doi: 10.1002/jcp.25920
20	Rahman MS , Akhtar N , Jamil HM , et al. TGF-beta/BMP signaling and other molecular events: Regulation of osteoblastogenesis and bone formation[J]. Bone Res, 2015, 3, 15005. doi: 10.1038/boneres.2015.5
21	Fan Y , Hanai JI , Le PT , et al. Parathyroid hormone directs bone marrow mesenchymal cell fate[J]. Cell Metab, 2017, 25 (3): 661- 672. doi: 10.1016/j.cmet.2017.01.001
22	Lim KE , Park NR , Che X , et al. Core binding factor beta of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice[J]. J Bone Miner Res, 2015, 30 (4): 715- 722. doi: 10.1002/jbmr.2397
23	Mishra R , Kumawat KL , Basu A , et al. Japanese encephalitis virus infection increases USP42 to stabilize TRIM21 and OAS1 for neuroinflammatory and anti-viral response in human microglia[J]. Virology, 2022, 573, 131- 140. doi: 10.1016/j.virol.2022.06.012
24	Matsui M , Sakasai R , Abe M , et al. USP42 enhances homologous recombination repair by promoting R-loop resolution with a DNA-RNA helicase DHX9[J]. Oncogenesis, 2020, 9 (6): 60. doi: 10.1038/s41389-020-00244-4
25	Liu S , Wang T , Shi Y , et al. USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis[J]. Cell Death Differ, 2021, 28 (8): 2482- 2498. doi: 10.1038/s41418-021-00763-6

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Gene	Forward primer (5′ to 3′)	Reverse primer (5′ to 3′)
GAPDH	GGAGCGAGATCCCTCCAAAAT	GGCTGTTGTCATACTTCTCATGG
USP42	AATCTTCAGACCCATCAGCCT	AGAACCTGCATCCATGTCTCC
ALP	ATGGGATGGGTGTCTCCACA	CCACGAAGGGGAACTTGTC
OSX	CCTCTGCGGGACTCAACAAC	TAAAGGGGGCTGGATAAGCAT
COLⅠ	TGGTCCCAAGGGTAACAGCG	AACACCAACAGGGCCAGGCT

[1]	简远志,王菲,尹宁,周若宇,王军波. 基于胚胎干细胞模型的Cry1Ab蛋白发育毒性[J]. 北京大学学报（医学版）, 2024, 56(2): 213-222.
[2]	陈晓颖,张一,李雨柯,唐琳,刘玉华. 不同种类聚合物对猪小肠黏膜下层支架仿生矿化的影响[J]. 北京大学学报（医学版）, 2024, 56(1): 17-24.
[3]	蓝璘,贺洋,安金刚,张益. 颧骨缺损不同修复重建方法和预后的回顾性分析[J]. 北京大学学报（医学版）, 2022, 54(2): 356-362.
[4]	赵健芳,李东,安阳. TET蛋白家族与5-羟甲基胞嘧啶在干细胞及再生医学表观遗传调控中的作用[J]. 北京大学学报（医学版）, 2021, 53(2): 420-424.
[5]	张胜男,安娜,欧阳翔英,刘颖君,王雪奎. 生长停滞特异性蛋白6在人牙周膜细胞迁移及成骨分化中的作用[J]. 北京大学学报（医学版）, 2021, 53(1): 9-15.
[6]	谢静,赵玉鸣,饶南荃,汪晓彤,方滕姣子,李晓霞,翟越,李静芝,葛立宏,王媛媛. 3种口腔颌面部来源的间充质干细胞成血管内皮分化潜能的比较研究[J]. 北京大学学报（医学版）, 2019, 51(5): 900-906.
[7]	隋华欣，吕培军，王勇，冯驭驰. 低能量激光照射对人脂肪来源干细胞/海藻酸钠/明胶三维生物打印体成骨能力的影响[J]. 北京大学学报(医学版), 2018, 50(5): 868-875.
[8]	隋华欣，吕培军，王宇光，王勇，孙玉春. 低能量激光照射对人脂肪基质细胞增殖分化的影响[J]. 北京大学学报(医学版), 2017, 49(2): 337-343.
[9]	凌龙，赵玉鸣，葛立宏. 不同炎症状态下犬年轻恒牙牙髓干细胞增殖及成骨分化能力的改变[J]. 北京大学学报(医学版), 2016, 48(5): 878-883.
[10]	俞光岩，曹彤，邹晓晖，张学慧，傅歆，彭双清，邓旭亮，李盛林，刘鹤，肖苒，欧阳宏伟，彭晖，陈晓，赵增明，王晓颖……. 基于人胚胎干细胞健康安全评价体系的构建[J]. 北京大学学报(医学版), 2016, 48(1): 1-4.
[11]	张晓，刘云松，吕珑薇，陈彤，吴刚，周永胜. 骨形态发生蛋白2/7异二聚体对人脂肪间充质干细胞成骨分化的促进作用[J]. 北京大学学报(医学版), 2016, 48(1): 37-44.
[12]	葛雯姝，汤祎熳，张晓，刘云松，周永胜. 构建一种可评价脂肪间充质干细胞成骨向分化的荧光素酶报告系统[J]. 北京大学学报(医学版), 2016, 48(1): 170-174.
[13]	王晓飞，吕培军，宋杨，王勇，孙玉春 . 短时CaCl2刺激对人脂肪干细胞增殖与成骨向分化的影响[J]. 北京大学学报(医学版), 2015, 47(6): 971-976.
[14]	贾双双，李伟阳，刘欣，李丽英. 转化生长因子-β1 通过产生活性氧诱导骨髓间充质干细胞分化为肌成纤维细胞[J]. 北京大学学报(医学版), 2015, 47(5): 737-742.
[15]	宋一萌, 马潞林, 李肖霞, 朱毅. 前列腺素E2促骨髓来源内皮前体细胞分化的机制[J]. 北京大学学报(医学版), 2015, 47(4): 577-581.